Lori A Hoerrner

Title: Lori A Hoerrner: Innovator in Monospecific Antibodies

Introduction

Lori A Hoerrner is a notable inventor based in Scotch Plains, NJ (US). She has made significant contributions to the field of biochemistry, particularly in the development of monospecific antibodies. Her work has implications for various inflammatory diseases and conditions.

Latest Patents

Lori A Hoerrner holds a patent for "Monospecific antibodies and assay system for detecting stromelysin." This invention involves the production of monospecific antibodies that are specific for fragments of the connective tissue protein aggrecan, which are generated by specific stromelysin cleavage. The assay system developed utilizes these antibodies to detect polypeptide fragments of aggrecan, indicating stromelysin activity. The presence of these fragments is crucial as elevations of stromelysin are associated with conditions such as osteoarthritis, rheumatoid arthritis, and certain cancers.

Career Highlights

Lori A Hoerrner is currently employed at Merck & Co., Inc., where she continues her research and development in the field of biochemistry. Her innovative work has led to advancements in understanding and quantifying stromelysin activity, which is vital for evaluating potential inhibitors.

Collaborations

Throughout her career, Lori has collaborated with esteemed colleagues, including Richard A Mumford and Michael W Lark. These collaborations have further enhanced her research and contributed to the success of her inventions.

Conclusion

Lori A Hoerrner's contributions to the field of monospecific antibodies and her innovative patent demonstrate her commitment to advancing medical science. Her work has the potential to impact the diagnosis and treatment of various inflammatory diseases significantly.